Atlanta Capital Management’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$38.2M Sell
901,115
-19,238
-2% -$815K 0.17% 118
2022
Q2
$49.7M Sell
920,353
-35,644
-4% -$1.93M 0.21% 113
2022
Q1
$61.4M Sell
955,997
-4,421
-0.5% -$284K 0.23% 110
2021
Q4
$64.3M Buy
960,418
+19,271
+2% +$1.29M 0.22% 113
2021
Q3
$64.5M Sell
941,147
-38,423
-4% -$2.63M 0.23% 109
2021
Q2
$66.8M Sell
979,570
-35,880
-4% -$2.45M 0.23% 109
2021
Q1
$70.2M Sell
1,015,450
-92,766
-8% -$6.41M 0.25% 102
2020
Q4
$71.9M Sell
1,108,216
-60,591
-5% -$3.93M 0.26% 99
2020
Q3
$55.2M Buy
1,168,807
+112,747
+11% +$5.32M 0.23% 111
2020
Q2
$49.6M Buy
1,056,060
+172,153
+19% +$8.09M 0.21% 114
2020
Q1
$39.5M Buy
883,907
+190,901
+28% +$8.53M 0.21% 111
2019
Q4
$40.4M Buy
693,006
+11,594
+2% +$676K 0.17% 115
2019
Q3
$40.9M Sell
681,412
-4,583
-0.7% -$275K 0.18% 107
2019
Q2
$38.3M Sell
685,995
-28,613
-4% -$1.6M 0.17% 108
2019
Q1
$39.8M Sell
714,608
-13,547
-2% -$755K 0.19% 106
2018
Q4
$32.8M Buy
728,155
+84,944
+13% +$3.83M 0.18% 109
2018
Q3
$42.4M Buy
643,211
+4,168
+0.7% +$275K 0.2% 97
2018
Q2
$41.2M Sell
639,043
-17,792
-3% -$1.15M 0.21% 88
2018
Q1
$36.3M Sell
656,835
-7,920
-1% -$438K 0.19% 99
2017
Q4
$31.8M Sell
664,755
-24,010
-3% -$1.15M 0.17% 106
2017
Q3
$34.8M Sell
688,765
-8,629
-1% -$436K 0.2% 102
2017
Q2
$38M Sell
697,394
-13,297
-2% -$725K 0.22% 92
2017
Q1
$29.9M Buy
710,691
+37,773
+6% +$1.59M 0.18% 114
2016
Q4
$28.9M Buy
672,918
+71,094
+12% +$3.05M 0.18% 116
2016
Q3
$24.8M Buy
+601,824
New +$24.8M 0.16% 124